Kainos Laboratories Inc (4556)

Currency in JPY
1,244.0
-10.0(-0.80%)
Closed·
4556 Scorecard
Full Analysis
Stock generally trades with low price volatility
4556 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,244.01,244.0
52 wk Range
1,035.01,321.0
Key Statistics
Bid/Ask
1,244.00 / 1,255.00
Prev. Close
1,254
Open
1,244
Day's Range
1,244-1,244
52 wk Range
1,035-1,321
Volume
400
Average Volume (3m)
1.55K
1-Year Change
3.93%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4556 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Kainos Laboratories Inc Company Profile

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Test Kit, a liquid form creatinine measurement reagent kit for various makes of automatic analyzer systems; Aqua-auto Kainos ALB Test Kit, a liquid form reagent kit; and Aqua-auto Kainos UN-II Test Kit, a liquid urea nitrogen measurement reagent kit. In addition, it provides FGF-23 ELISA Kit, a two-site enzyme-linked immunosorbent assay kit for the measurement of FGF-23 in serum. Further, the company offers point of care testing solutions comprising Swiftgene Norovirus GI/GII Kainos for detecting noroviruses; Statmark FLUstick II for detecting type A and type B influenza virus antigens; and Statmark Strep A for detecting Group A beta-hemolytic streptococci. The company was formerly known as DOMS-IATRON Co., Ltd. and changed its name to KAINOS Laboratories, Inc. in July 1975. KAINOS Laboratories, Inc. was founded in 1975 and is headquartered in Tokyo, Japan.

Employees
133
Market
Japan

Compare 4556 to Peers and Sector

Metrics to compare
4556
Peers
Sector
Relationship
P/E Ratio
0.0x12.2x−0.5x
PEG Ratio
0.00−0.080.00
Price/Book
0.0x1.6x2.6x
Price / LTM Sales
0.0x2.5x3.2x
Upside (Analyst Target)
0.0%26.9%42.0%
Fair Value Upside
Unlock8.1%6.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 18.58%
Dividend Yield
2.81%
Industry Median 1.31%
Annualised payout
35.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
43.57 / --
Revenue / Forecast
1.43B / --
EPS Revisions
Last 90 days

4556 Income Statement

FAQ

What Stock Exchange Does Kainos Laboratories Trade On?

Kainos Laboratories is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Kainos Laboratories?

The stock symbol for Kainos Laboratories is "4556."

What Is the Kainos Laboratories Market Cap?

As of today, Kainos Laboratories market cap is 5.53B.

What Is Kainos Laboratories's Earnings Per Share (TTM)?

The Kainos Laboratories EPS (TTM) is 18.58.

When Is the Next Kainos Laboratories Earnings Date?

Kainos Laboratories will release its next earnings report on 27 Oct 2025.

From a Technical Analysis Perspective, Is 4556 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Kainos Laboratories Stock Split?

Kainos Laboratories has split 0 times.

How Many Employees Does Kainos Laboratories Have?

Kainos Laboratories has 133 employees.

What is the current trading status of Kainos Laboratories (4556)?

As of 30 Jul 2025, Kainos Laboratories (4556) is trading at a price of 1,244.00, with a previous close of 1,254.00. The stock has fluctuated within a day range of 1,244.00 to 1,244.00, while its 52-week range spans from 1,035.00 to 1,321.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.